Gabriella Rozera

Medicine & Life Sciences

1. Quasispecies 100%
2. HIV-1 99%
3. High-Throughput Nucleotide Sequencing 92%
4. HIV 53%
5. p17 protein, Human Immunodeficiency Virus Type 1 46%
6. HIV Infections 33%
7. DNA 29%
8. Tropism 27%
9. Genome 24%
10. Highly Active Antiretroviral Therapy 18%
11. Molecular Dynamics Simulation 16%
12. Italy 16%
13. Drug Resistance 15%
14. HIV Envelope Protein gp120 14%
15. Infections 14%
16. CXCR4 Receptors 13%
17. Viremia 13%
18. Mutation 13%
19. RNA 13%
20. SARS Virus 11%
21. Population 11%
22. CCR5 Receptors 10%
23. Hemagglutinins 10%
24. Non-Hodgkin's Lymphoma 10%
25. Viruses 10%
26. Therapeutics 10%
27. Antiviral Agents 10%
28. Viral Load 9%
29. Virus Replication 9%
30. Human Influenza 9%
31. T-Lymphocytes 9%
32. Pandemics 9%
33. CD4 Antigens 9%
34. Raltegravir Potassium 8%
35. Multicenter Studies 8%
36. Monkeypox 8%
37. Monocytes 8%
38. Genetic Heterogeneity 7%
39. Disease Outbreaks 7%
40. Proviruses 7%
41. Viral RNA 7%
42. Life Cycle Stages 6%
43. entecavir 6%
44. Ebola Hemorrhagic Fever 6%
45. Virus Integration 6%
46. Human immunodeficiency virus 1 reverse transcriptase 6%
47. Ebolavirus 6%
48. Integrases 6%
49. Hepatitis A virus 6%
50. Virology 6%